Skip to main content
. 2025 May 23;18(6):sfaf159. doi: 10.1093/ckj/sfaf159

Figure 1:

Figure 1:

Cohort selection flow chart. Flow chart illustrates the selection process for HD sessions included in the study. A total of 39 371 eligible sessions were assessed for exposure to four classes of antihypertensive drugs: ACEIs/ARBs, alpha blockers, beta blockers and DHP-CCBs. It was possible for a session to have exposure status for multiple classes of antihypertensive drugs.